Mussel polysaccharide ameliorates dextran sulfate sodium-induced colitis by suppressing CXCL5-mediated neutrophil migration and modulating gut microbiota homeostasis
The exact mechanisms through which mussel polysaccharides (MP) affect innate immune responses and gut microbiota in inflammatory bowel disease (IBD) have not been fully understood despite reports of their anti-inflammatory and immunomodulatory effects. In the present study, a novel mussel polysaccharide was characterized as a predominantly →4)-α-D-Glcp-(1 → glucan with branching-related linkages occurring at an approximate ratio of 2:9 relative to 4-linked Glcp residues, with O-6 substitution representing the major branching pattern. The treatment with MP led to improved intestinal barrier function and reduced pro-inflammatory cytokine production. Mechanistically, MP may directly interact with TLR4 on intestinal epithelial cells and attenuate TLR4-associated NF-κB and JAK2/STAT3 signaling, thereby reducing CXCL5 production and limiting CXCL5-mediated neutrophil recruitment. The 16S rRNA sequencing showed that MP administration was associated with alterations in gut microbial diversity and community composition. Collectively, our research demonstrates MP as an effective dietary treatment for supporting intestinal barrier and immune homeostasis under colitis-like inflammatory conditions.
Authors
- Zhuoting Li (ORCID: https://orcid.org/0009-0006-8106-0460)
- Hanxi Ding (ORCID: https://orcid.org/0009-0008-2455-6683)
- Shuaijie Hu
- Zhongqi Li
- Xiangyu Cheng
- Ziqi Tang
- Yuhe Lu
- Weiduo Wan
- Yuanyuan Lu
- Qinghua Hu
Institutions
- China Pharmaceutical University (CN)
Publication Details
- Journal
- Journal of Functional Foods
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.jff.2026.107586
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00